Biogen Inc Stock Return On Equity

BIIB Stock

USD 194.11 0.27 0.14%

Biogen Inc fundamentals help investors to digest information that contributes to Biogen's financial success or failures. It also enables traders to predict the movement of Biogen Stock. The fundamental analysis module provides a way to measure Biogen's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Biogen stock.

		Last Reported	Projected for Next Year
	Return On Equity	0.08	0.1

The current year's Return On Equity is expected to grow to 0.1.

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Biogen Inc Company Return On Equity Analysis

Biogen's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Return On Equity

Net Income

Total Equity

More About Return On Equity | All Equity Analysis

Current Biogen Return On Equity

0.0824

Most of Biogen's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Biogen Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Biogen Return On Equity Driver Correlations

Understanding the fundamental principles of building solid financial models for Biogen is extremely important. It helps to project a fair market value of Biogen Stock properly, considering its historical fundamentals such as Return On Equity. Since Biogen's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Biogen's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Biogen's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Net Receivables	Total Liab	Total Current Assets	Intangible Assets	Accounts Payable	Short Term Investments	Common Stock	Short Term Debt	Long Term Debt	Property Plant Equipment	Current Deferred Revenue	Treasury Stock	Good Will	Net Tangible Assets	Long Term Debt Total	Capital Surpluse	Deferred Long Term Liab	Long Term Investments	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.94	0.85	0.99	0.97	0.96	0.93	0.59	0.89	0.3	-0.8	0.39	0.89	0.89	0.23	-0.92	0.85	0.26	0.81	-0.95	0.45	-0.08	0.5	-0.18	-0.19	-0.38
Total Stockholder Equity	0.94		0.68	0.94	0.95	0.82	0.87	0.7	0.79	0.18	-0.85	0.29	0.74	0.81	0.36	-0.88	0.7	0.46	0.63	-0.82	0.32	-0.11	0.32	-0.21	-0.05	-0.46
Net Debt	0.85	0.68		0.83	0.78	0.91	0.73	0.54	0.71	0.22	-0.56	0.22	0.96	0.72	0.34	-0.69	0.76	0.0	0.91	-0.91	0.28	-0.15	0.4	-0.04	-0.34	-0.46
Retained Earnings	0.99	0.94	0.83		0.97	0.94	0.93	0.61	0.83	0.28	-0.73	0.33	0.89	0.84	0.29	-0.91	0.83	0.35	0.82	-0.94	0.38	-0.04	0.42	-0.22	-0.1	-0.41
Net Receivables	0.97	0.95	0.78	0.97		0.9	0.89	0.6	0.85	0.18	-0.75	0.32	0.84	0.86	0.3	-0.9	0.84	0.37	0.75	-0.88	0.4	-0.14	0.45	-0.3	-0.07	-0.42
Total Liab	0.96	0.82	0.91	0.94	0.9		0.91	0.44	0.89	0.37	-0.69	0.44	0.94	0.87	0.11	-0.88	0.9	0.09	0.9	-0.98	0.51	-0.05	0.6	-0.14	-0.28	-0.28
Total Current Assets	0.93	0.87	0.73	0.93	0.89	0.91		0.35	0.85	0.53	-0.76	0.33	0.86	0.85	0.01	-0.92	0.82	0.3	0.82	-0.94	0.35	0.22	0.41	-0.35	0.05	-0.13
Intangible Assets	0.59	0.7	0.54	0.61	0.6	0.44	0.35		0.32	-0.35	-0.53	-0.08	0.46	0.34	0.84	-0.44	0.25	0.36	0.31	-0.45	0.01	-0.45	-0.08	0.11	-0.24	-0.82
Accounts Payable	0.89	0.79	0.71	0.83	0.85	0.89	0.85	0.32		0.25	-0.71	0.5	0.75	0.88	0.0	-0.85	0.86	0.12	0.7	-0.84	0.52	-0.14	0.61	-0.27	-0.21	-0.2
Short Term Investments	0.3	0.18	0.22	0.28	0.18	0.37	0.53	-0.35	0.25		-0.36	0.29	0.36	0.39	-0.64	-0.42	0.3	-0.17	0.45	-0.46	0.17	0.77	0.3	-0.01	0.1	0.58
Common Stock	-0.8	-0.85	-0.56	-0.73	-0.75	-0.69	-0.76	-0.53	-0.71	-0.36		-0.22	-0.61	-0.77	-0.15	0.79	-0.51	-0.21	-0.52	0.72	-0.2	-0.05	-0.25	0.11	0.1	0.22
Short Term Debt	0.39	0.29	0.22	0.33	0.32	0.44	0.33	-0.08	0.5	0.29	-0.22		0.18	0.45	-0.37	-0.35	0.49	-0.02	0.18	-0.34	0.85	-0.16	0.88	0.15	-0.32	0.08
Long Term Debt	0.89	0.74	0.96	0.89	0.84	0.94	0.86	0.46	0.75	0.36	-0.61	0.18		0.77	0.24	-0.78	0.81	0.09	0.96	-0.96	0.24	0.03	0.36	-0.21	-0.15	-0.35
Property Plant Equipment	0.89	0.81	0.72	0.84	0.86	0.87	0.85	0.34	0.88	0.39	-0.77	0.45	0.77		-0.01	-0.87	0.92	0.27	0.8	-0.86	0.44	-0.03	0.58	-0.07	-0.25	-0.06
Current Deferred Revenue	0.23	0.36	0.34	0.29	0.3	0.11	0.01	0.84	0.0	-0.64	-0.15	-0.37	0.24	-0.01		-0.01	-0.01	0.43	0.09	-0.13	-0.28	-0.5	-0.41	0.0	-0.06	-0.9
Treasury Stock	-0.92	-0.88	-0.69	-0.91	-0.9	-0.88	-0.92	-0.44	-0.85	-0.42	0.79	-0.35	-0.78	-0.87	-0.01		-0.8	-0.2	-0.76	0.87	-0.36	-0.09	-0.48	0.17	0.13	0.11
Good Will	0.85	0.7	0.76	0.83	0.84	0.9	0.82	0.25	0.86	0.3	-0.51	0.49	0.81	0.92	-0.01	-0.8		0.25	0.86	-0.85	0.53	-0.1	0.66	-0.14	-0.26	-0.09
Net Tangible Assets	0.26	0.46	0.0	0.35	0.37	0.09	0.3	0.36	0.12	-0.17	-0.21	-0.02	0.09	0.27	0.43	-0.2	0.25		0.1	-0.14	-0.1	0.0	-0.21	-0.21	0.34	-0.29
Long Term Debt Total	0.81	0.63	0.91	0.82	0.75	0.9	0.82	0.31	0.7	0.45	-0.52	0.18	0.96	0.8	0.09	-0.76	0.86	0.1		-0.93	0.23	0.12	0.39	-0.12	-0.19	-0.13
Capital Surpluse	-0.95	-0.82	-0.91	-0.94	-0.88	-0.98	-0.94	-0.45	-0.84	-0.46	0.72	-0.34	-0.96	-0.86	-0.13	0.87	-0.85	-0.14	-0.93		-0.38	-0.1	-0.46	0.18	0.15	0.26
Deferred Long Term Liab	0.45	0.32	0.28	0.38	0.4	0.51	0.35	0.01	0.52	0.17	-0.2	0.85	0.24	0.44	-0.28	-0.36	0.53	-0.1	0.23	-0.38		-0.24	0.9	0.11	-0.41	0.02
Long Term Investments	-0.08	-0.11	-0.15	-0.04	-0.14	-0.05	0.22	-0.45	-0.14	0.77	-0.05	-0.16	0.03	-0.03	-0.5	-0.09	-0.1	0.0	0.12	-0.1	-0.24		-0.25	-0.14	0.44	0.59
Short Long Term Debt	0.5	0.32	0.4	0.42	0.45	0.6	0.41	-0.08	0.61	0.3	-0.25	0.88	0.36	0.58	-0.41	-0.48	0.66	-0.21	0.39	-0.46	0.9	-0.25		0.14	-0.48	0.13
Net Invested Capital	-0.18	-0.21	-0.04	-0.22	-0.3	-0.14	-0.35	0.11	-0.27	-0.01	0.11	0.15	-0.21	-0.07	0.0	0.17	-0.14	-0.21	-0.12	0.18	0.11	-0.14	0.14		-0.79	0.13
Net Working Capital	-0.19	-0.05	-0.34	-0.1	-0.07	-0.28	0.05	-0.24	-0.21	0.1	0.1	-0.32	-0.15	-0.25	-0.06	0.13	-0.26	0.34	-0.19	0.15	-0.41	0.44	-0.48	-0.79		0.08
Capital Stock	-0.38	-0.46	-0.46	-0.41	-0.42	-0.28	-0.13	-0.82	-0.2	0.58	0.22	0.08	-0.35	-0.06	-0.9	0.11	-0.09	-0.29	-0.13	0.26	0.02	0.59	0.13	0.13	0.08

Click cells to compare fundamentals

For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.

Competition

Predict Biogen

Return On Equity Over Time

Biogen Total Stockholder Equity

Total Stockholder Equity

15.54 Billion

At present, Biogen's Total Stockholder Equity is projected to increase significantly based on the last few years of reporting.

Based on the latest financial disclosure, Biogen Inc has a Return On Equity of 0.0824. This is 100.34% lower than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The return on equity for all United States stocks is 126.58% lower than that of the firm.

Biogen Return On Equity Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Biogen's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Biogen could also be used in its relative valuation, which is a method of valuing Biogen by comparing valuation metrics of similar companies.

Biogen is currently under evaluation in return on equity category among related companies.

Biogen ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Biogen's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Biogen's managers, analysts, and investors.

Environment Score

Governance Score

Social Score

Biogen Fundamentals

	Return On Equity	0.0824
	Return On Asset	0.0458
	Profit Margin	0.12 %
	Operating Margin	0.19 %
	Current Valuation	34.63 B
	Shares Outstanding	145.36 M
	Shares Owned By Insiders	0.68 %
	Shares Owned By Institutions	92.98 %
	Number Of Shares Shorted	3.55 M
	Price To Earning	14.83 X
	Price To Book	1.95 X
	Price To Sales	2.93 X
	Revenue	9.84 B
	Gross Profit	7.9 B
	EBITDA	2.6 B
	Net Income	1.16 B
	Cash And Equivalents	4.91 B
	Cash Per Share	34.10 X
	Total Debt	7.34 B
	Debt To Equity	0.52 %
	Current Ratio	2.49 X
	Book Value Per Share	102.14 X
	Cash Flow From Operations	1.55 B
	Short Ratio	2.66 X
	Earnings Per Share	7.97 X
	Price To Earnings To Growth	6.24 X
	Target Price	298.83
	Number Of Employees	7.57 K
	Beta	-0.009
	Market Capitalization	28.26 B
	Total Asset	26.84 B
	Retained Earnings	17.63 B
	Working Capital	3.42 B
	Current Asset	8.73 B
	Current Liabilities	3.42 B
	Net Asset	26.84 B

About Biogen Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Biogen Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biogen using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biogen Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Pair Trading with Biogen

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Biogen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biogen will appreciate offsetting losses from the drop in the long position's value.

Moving together with Biogen Stock

0.7

JNJ

Johnson Johnson Aggressive Push

Pair Corr

Moving against Biogen Stock

0.83	PAHC	Phibro Animal Health Financial Report 1st of May 2024	Pair Corr
0.8	OPT	Opthea	Pair Corr
0.8	CNTA	Centessa Pharmaceuticals Downward Rally	Pair Corr
0.77	ANIP	ANI Pharmaceuticals Financial Report 13th of May 2024	Pair Corr
0.64	AVTE	Aerovate Therapeutics Financial Report 20th of May 2024	Pair Corr

The ability to find closely correlated positions to Biogen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Biogen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Biogen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Biogen Inc to buy it.

The correlation of Biogen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Biogen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Biogen Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Biogen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Biogen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biogen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biogen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biogen Inc Stock:

How To Invest In Biogen

Details

Is Biogen Stock a good investment?

Details

What is Biogen's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Biogen Piotroski F Score and Biogen Altman Z Score analysis.

You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Complementary Tools for Biogen Stock analysis

When running Biogen's price analysis, check to measure Biogen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biogen is operating at the current time. Most of Biogen's value examination focuses on studying past and present price action to predict the probability of Biogen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biogen's price. Additionally, you may evaluate how the addition of Biogen to your portfolios can decrease your overall portfolio volatility.

	Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market.
	Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios
	Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
	AI Investment Finder Use AI to screen and filter profitable investment opportunities
	Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities
	Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years
	Share Portfolio Track or share privately all of your investments from the convenience of any device
	Economic Indicators Top statistical indicators that provide insights into how an economy is performing
	Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
	Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios
	Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges
	Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk
	Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format

Is Biogen's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biogen. If investors know Biogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.55)

Earnings Share

7.97

Revenue Per Share

67.972

Quarterly Revenue Growth

(0.06)

Return On Assets

0.0458

The market value of Biogen Inc is measured differently than its book value, which is the value of Biogen that is recorded on the company's balance sheet. Investors also form their own opinion of Biogen's value that differs from its market value or its book value, called intrinsic value, which is Biogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biogen's market value can be influenced by many factors that don't directly affect Biogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Biogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Biogen Inc Stock Return On Equity

Biogen Inc Company Return On Equity Analysis

Return On Equity

Net Income

Total Equity

Current Biogen Return On Equity

Biogen Return On Equity Driver Correlations

Biogen Total Stockholder Equity

Total Stockholder Equity

15.54 Billion

Biogen Return On Equity Peer Comparison

Biogen ESG Sustainability

Biogen Fundamentals

About Biogen Fundamental Analysis

Pair Trading with Biogen

Moving together with Biogen Stock

Moving against Biogen Stock

Complementary Tools for Biogen Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY